Clinical Trials Browser

Phase 1 × Small Cell Lung Carcinoma × guadecitabine × Clear all

NCT03085849 2018-12-10

SGI-110 Plus Durvalumab/Tremelimumab in SCLC

Phase 1 Completed

Small Cell Lung Carcinoma